We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$5B
AUM Growth
+$569M
(+13%)
Cap. Flow
+$104M
Cap. Flow
% of AUM
2.08%
Top 10 Holdings %
Top 10 Hldgs %
38.84%
Holding
3,762
New
251
Increased
1,450
Reduced
1,277
Closed
224
Avg Time Held Equity + Options
4.7
years
Top 10 Avg Time Held Equity + Options
2.9
years
Top 20 Avg Time Held Equity + Options
3.8
years
Avg Time Held Equity only
4.7
years
Top 10 Avg Time Held Equity only
2.9
years
Top 20 Avg Time Held Equity only
3.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$18.4M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$9.77M |
| 3 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$5.48M |
| 4 |
Microsoft
MSFT
|
+$4.93M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$4.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corcept Therapeutics
CORT
|
+$7.34M |
| 2 |
Starbucks
SBUX
|
+$4.7M |
| 3 |
iShares California Muni Bond ETF
CMF
|
+$3.3M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.63M |
| 5 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$1.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.71% |
| 2 | Technology | 17.21% |
| 3 | Healthcare | 9.68% |
| 4 | Financials | 7.2% |
| 5 | Communication Services | 5.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3226
Generation Income Properties
GIPR
$1.21M
| $730 | ﹤0.01% |
50
| – | – |
2022 Q3
11 quarters
|
|
3227
Horace Mann Educators
HMN
$1.86B
| $730 | ﹤0.01% |
17
| – | – |
2021 Q1
17 quarters
|
|
3228
Sweetgreen
SG
$1.26B
| $715 | ﹤0.01% |
48
-44
| -48% | -$725 |
2024 Q2
4 quarters
|
|
3229
Bowhead Specialty Holdings
BOW
$1.12B
| $713 | ﹤0.01% |
+19
| New | +$728 |
2025 Q2
0 quarters
|
|
3230
United Parks & Resorts
PRKS
$1.48B
| $707 | ﹤0.01% |
15
-10
| -40% | -$447 |
2023 Q1
9 quarters
|
|
3231
Unity Bancorp
UNTY
$564M
| $706 | ﹤0.01% |
+15
| New | +$647 |
2025 Q2
0 quarters
|
|
3232
Medifast
MED
$135M
| $703 | ﹤0.01% |
+50
| New | +$657 |
2025 Q2
0 quarters
|
|
3233
Skyward Specialty Insurance
SKWD
$2.67B
| $693 | ﹤0.01% |
+12
| New | +$692 |
2025 Q2
0 quarters
|
|
3234
Cushman & Wakefield Ltd
CWK
$2.73B
| $686 | ﹤0.01% |
62
+12
| +24% | +$118 |
2023 Q4
6 quarters
|
|
3235
Forrester Research
FORR
$227M
| $683 | ﹤0.01% |
+69
| New | +$686 |
2025 Q2
0 quarters
|
|
3236
Centuri Holdings
CTRI
$2B
| $673 | ﹤0.01% |
30
+5
| +20% | +$98 |
2025 Q1
1 quarter
|
|
3237
Astrana Health
ASTH
$1.89B
| $672 | ﹤0.01% |
+27
| New | +$760 |
2025 Q2
0 quarters
|
|
3238
Universal Electronics
UEIC
$66.6M
| $662 | ﹤0.01% |
100
| – | – |
2024 Q2
4 quarters
|
|
3239
Gorman-Rupp
GRC
$1.91B
| $661 | ﹤0.01% |
18
| – | – |
2023 Q2
8 quarters
|
|
3240
Century Aluminum
CENX
$3.39B
| $649 | ﹤0.01% |
36
-13
| -27% | -$221 |
2022 Q3
11 quarters
|
|
3241
FrontView REIT
FVR
$418M
| $648 | ﹤0.01% |
+54
| New | +$639 |
2025 Q2
0 quarters
|
|
3242
Taysha Gene Therapies
TSHA
$1.22B
| $647 | ﹤0.01% |
280
| – | – |
2024 Q2
4 quarters
|
|
3243
DELISTED
Thermon Group Holdings
THR
| $646 | ﹤0.01% |
23
| – | – |
2022 Q3
11 quarters
|
|
3244
Direxion Daily MSCI Emerging Markets Bull 3X ETF
EDC
$145M
| $641 | ﹤0.01% |
16
| – | – |
2024 Q2
4 quarters
|
|
3245
Intuitive Machines
LUNR
$1.87B
| $641 | ﹤0.01% |
59
-336
| -85% | -$3.29K |
2024 Q4
2 quarters
|
|
3246
Magnera Corp
MAGN
$401M
| $640 | ﹤0.01% |
53
-16
| -23% | -$220 |
2024 Q4
2 quarters
|
|
3247
Ezcorp Inc
EZPW
$2.04B
| $638 | ﹤0.01% |
46
+19
| +70% | +$275 |
2024 Q2
4 quarters
|
|
3248
Nano Dimension
NNDM
$607M
| $634 | ﹤0.01% |
+391
| New | +$598 |
2025 Q2
0 quarters
|
|
3249
Merchants Bancorp
MBIN
$2.25B
| $628 | ﹤0.01% |
19
-56
| -75% | -$1.81K |
2022 Q2
12 quarters
|
|
3250
First Trust Rising Dividend Achievers ETF
RDVY
$25.5B
| $627 | ﹤0.01% |
10
| – | – |
2024 Q4
2 quarters
|
|
Similar funds
Parallel Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Parallel Advisors's Q2 2025 filing shows 251 new, 1,450 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 47% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
- Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
- Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
- Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
- Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
- Parallel Advisors opened 251 new positions and closed 224 in Q2 2025.
- Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.
Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.